ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,650.74
0.35%
US Tech 100
19,783.60
-0.31%
다우존스 지수
40,828.80
1.53%
Bitcoin
64,336.02
-0.79%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) 뉴스

AVDL

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AVDL
일자시간출처헤드라인심볼기업
2023/02/1420:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/02/1406:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/02/0822:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/02/0322:00GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/01/2507:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/01/2422:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly OxybatesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/01/2406:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/01/1106:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/12/2906:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/12/2006:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/12/0206:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/2406:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/2222:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/2206:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/2120:25TipRanksNeedham Sticks to Their Buy Rating for Avadel Pharmaceuticals (AVDL)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/1906:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/1905:45TipRanksAvadel Pharmaceuticals (AVDL) Receives a Buy from LifeSci CapitalNASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/1904:44GlobeNewswire Inc.Avadel Pharmaceuticals Announces Favorable Ruling on Motion to Delist REMS Patent from FDA’s Orange BookNASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/1620:15TipRanksH.C. Wainwright Sticks to Its Buy Rating for Avadel Pharmaceuticals (AVDL)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/1412:56TipRanksSVB Securities Remains a Buy on Avadel Pharmaceuticals (AVDL)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/1022:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Jefferies London Healthcare ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/1019:15TipRanksNeedham Reaffirms Their Buy Rating on Avadel Pharmaceuticals (AVDL)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/0923:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/0921:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/0921:30GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/0806:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/0420:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/11/0305:05GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 9NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/10/2505:05GlobeNewswire Inc.Avadel Presents New Real-World Data Describing Demographic Characteristics and Comorbidities of Patients with Narcolepsy at ANA 2022NASDAQ:AVDLAvadel Pharmaceuticals PLC
2022/09/2221:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Healthcare ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
 검색 관련기사 보기:NASDAQ:AVDL

최근 히스토리

BIT
P20GT8
NLBNPIT20GT8 20240918 5100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유